Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo. - Wikidata - wikimedia - TriplyDB

Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo.

Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo.

http://www.wikidata.org/entity/Q40090989

about

The effects of acylation stimulating protein supplementation VS antibody neutralization on energy expenditure in wildtype mice.The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.The Controversial C5a Receptor C5aR2: Its Role in Health and Disease.Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels.Complement-Mediated Regulation of Metabolism and Basic Cellular Processes The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance.Keeping It All Going-Complement Meets Metabolism Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice.The molecular mechanism of acylation stimulating protein regulation of adipophilin and perilipin expression: involvement of phosphoinositide 3-kinase and phospholipase C.Targeting complement-mediated immunoregulation for cancer immunotherapy.

P2860

Q33563258-2BAC4CB5-CBB5-496F-9D97-258E85D11324 Q33748190-AECB4A27-DE07-415B-B766-0A8F4C27ACD3 Q33863754-E4989FE0-A247-4F3F-AEBC-F4ABCF8FA0A7 Q37190372-0C45B253-89A3-442F-9AB3-F78A0C4C41D1 Q37248499-9BA01ADE-1695-414D-8C7D-070754B4B9E5 Q37280702-F5CAEA1B-FE9D-439D-BF3B-4512ECDB3397 Q37590579-E576F93A-B281-4688-87D3-2D46CD811462 Q38294970-80AAD5E5-5136-4806-808E-096144DC756D Q42814308-F3E4CBC2-0B71-4B46-834A-B8503ECB29FC Q49898514-EFA665A0-7F67-4673-8585-C01C50C1C95D

P2860

Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo.

http://www.wikidata.org/entity/Q40090989

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Acylation-stimulating protein/ ...... tabolism in vitro and in vivo.

@en

type

label

Acylation-stimulating protein/ ...... tabolism in vitro and in vivo.

@en

prefLabel

Acylation-stimulating protein/ ...... tabolism in vitro and in vivo.

@en

P1433

Q40090989-A994DE58-8743-47D5-8E28-7658020333A2

P1476

Q40090989-A25C86E8-D612-43DF-A2B1-2066FA619B31

P2093

Q40090989-210BEBCC-B52D-4DA6-85CB-7A6C1DFF8D62

Q40090989-581DFD87-C19D-4801-B198-6BE270D12290

Q40090989-5E3D1B77-86D5-4BA7-A90F-66480063E4A7

Q40090989-9D5A8E1E-2382-4BEC-856B-8B3EE19F853E

Q40090989-A2E083DF-CE25-4B23-ADD6-DE5873D4DFE3

Q40090989-A450B8DD-D8DD-4CCC-B311-9A82CE4EFE83

Q40090989-CAA00D69-1B53-4F17-99F1-C3E041141B54

P2860

Q40090989-0CFF3495-2A1E-4AC6-8913-BAB2A846207A

Q40090989-10861408-2751-472A-A667-5BD12F075908

Q40090989-1FD83A46-7E63-4910-99C1-88C8BE510424

Q40090989-256AD031-91EA-4B24-9798-CDA87DDB9619

Q40090989-2860F366-74FA-436B-A3D4-1B6DD1E73538

Q40090989-2E3224B0-CB26-4589-BDBE-ECE0324A76D3

Q40090989-3784E513-C6E8-4C03-A923-36A9ABD8788B

Q40090989-44D454E4-6FC2-4F89-970F-D2E4A550E10D

Q40090989-5F922872-4373-4EB8-A9A2-B482866808D6

Q40090989-6774B87C-1211-4C0D-85AE-320DBDF973C9

P304

Q40090989-425F97FB-C2C8-4124-A107-C09501931273

P31

Q40090989-C8AD98B4-C8C2-4304-B90C-78312F3DBCA2

P356

Q40090989-D161E26E-8E2E-4020-8094-1531DB9B1E2D

P433

Q40090989-1524B91F-C349-4775-BF33-391D1793EA60

P478

Q40090989-FBBA1138-93C4-451C-A66E-C5642DAA6604

P50

Q40090989-0DA7A3A2-2263-4624-88E2-041FBB8527DA

P577

Q40090989-8B62F034-5D8A-4F0A-BB65-6DA6A957B53E

P5875

Q40090989-B9B36C76-5C95-4614-BF7A-133EC5F77DE2

P698

Q40090989-77E82CB5-6EB6-4758-9A66-12D970C5C4CD

P921

Q40090989-249C8359-32C5-4F39-8CB8-904C2C3BFDC8

P356

AJPENDO.00565.2006

P1433

American Journal of Physiology - Endocrinology and Metabolism

P1476

Acylation-stimulating protein/ ...... tabolism in vitro and in vivo.

@en

P2093

Christian Roy

http://www.w3.org/2001/XMLSchema#string

David Kalant

http://www.w3.org/2001/XMLSchema#string

Huiling Lu

http://www.w3.org/2001/XMLSchema#string

Mathieu Laplante

http://www.w3.org/2001/XMLSchema#string

Sabina Paglialunga

http://www.w3.org/2001/XMLSchema#string

Wei Cui

http://www.w3.org/2001/XMLSchema#string

Yves Deshaies

http://www.w3.org/2001/XMLSchema#string

P2860

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss

The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein

C5L2 is a functional receptor for acylation-stimulating protein

Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line

The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis

Acylation stimulating protein (ASP), an adipocyte autocrine: new directions.

Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations.

Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice.

Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men.

Characterisation of G-protein-coupled receptors by antibodies.

P304

E1482-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPENDO.00565.2006

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

293

http://www.w3.org/2001/XMLSchema#string

P50

Katherine Cianflone

P577

2007-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6127955

http://www.w3.org/2001/XMLSchema#string

P698

17711993

http://www.w3.org/2001/XMLSchema#string

P921